Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Bullboard Posts
Comment by inforcashon Nov 19, 2007 11:14am
330 Views
Post# 13829666

RE: Just wondering

RE: Just wonderingHope we become 3-4 bagger like TH is short-time frame, though seems some downward pressure this morning---hoping its just the regular market.

I also follow TH and have some shares. BMO has a good report out for this, I believe target is $18.50---available on the BB. My take on TH: lost some ground recently due to overall mkt + lack of recent news. Announcement of 2nd indication expected in coming weeks, so if you don't own some, nows the time to load up IMO---I got some more in August  when it dipped below $9. Also looking forward to report on ins reimbursement potential in US. All the stars are aligned in that story, so pretty safe bet.

IFC
Bullboard Posts